Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Klaus Godl

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Antiviral Research|May 8, 2013
Profiling of the kinome of cytomegalovirus-infected cells reveals the functional importance of host kinases Aurora A, ABL and AMPKCorina Hutterer, Sebastian Karl Wandinger, Sabrina Wagner, et al.
Cancer Research|February 8, 2005
Cellular targets of gefitinibDirk Brehmer, Zoltán Greff, Klaus Godl, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 12, 2003
An efficient proteomics method to identify the cellular targets of protein kinase inhibitorsKlaus Godl, Josef Wissing, Alexander Kurtenbach, et al.
Molecular & Cellular Proteomics : MCP|October 12, 2004
Chemical proteomic analysis reveals alternative modes of action for pyrido[2,3-d]pyrimidine kinase inhibitorsJosef Wissing, Klaus Godl, Dirk Brehmer, et al.
The Journal of Biological Chemistry|October 11, 2002
The N terminus of the MUC2 mucin forms trimers that are held together within a trypsin-resistant core fragmentKlaus Godl, Malin E V Johansson, Martin E Lidell, et al.
Neoplasia (New York, N.Y.)|December 2, 2011
Disclosure of erlotinib as a multikinase inhibitor in pancreatic ductal adenocarcinomaLaura Conradt, Klaus Godl, Christoph Schaab, et al.
Cancer Research|August 3, 2005
Proteomic characterization of the angiogenesis inhibitor SU6668 reveals multiple impacts on cellular kinase signalingKlaus Godl, Oliver J Gruss, Jan Eickhoff, et al.
European Journal of Cancer (Oxford, England : 1990)|December 19, 2012
New insights into the molecular mechanisms underlying sensitivity/resistance to the atypical retinoid ST1926 in acute myeloid leukaemia cells: the role of histone H2A.Z, cAMP-dependent protein kinase A and the proteasomeMaddalena Fratelli, James Neil Fisher, Gabriela Paroni, et al.
Antiviral Research|November 8, 2015
The broad-spectrum antiinfective drug artesunate interferes with the canonical nuclear factor kappa B (NF-κB) pathway by targeting RelA/p65Corina Hutterer, Ina Niemann, Jens Milbradt, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Antiviral Research|May 8, 2013
Profiling of the kinome of cytomegalovirus-infected cells reveals the functional importance of host kinases Aurora A, ABL and AMPKCorina Hutterer, Sebastian Karl Wandinger, Sabrina Wagner, et al.
Cancer Research|February 8, 2005
Cellular targets of gefitinibDirk Brehmer, Zoltán Greff, Klaus Godl, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 12, 2003
An efficient proteomics method to identify the cellular targets of protein kinase inhibitorsKlaus Godl, Josef Wissing, Alexander Kurtenbach, et al.
Molecular & Cellular Proteomics : MCP|October 12, 2004
Chemical proteomic analysis reveals alternative modes of action for pyrido[2,3-d]pyrimidine kinase inhibitorsJosef Wissing, Klaus Godl, Dirk Brehmer, et al.
The Journal of Biological Chemistry|October 11, 2002
The N terminus of the MUC2 mucin forms trimers that are held together within a trypsin-resistant core fragmentKlaus Godl, Malin E V Johansson, Martin E Lidell, et al.
Neoplasia (New York, N.Y.)|December 2, 2011
Disclosure of erlotinib as a multikinase inhibitor in pancreatic ductal adenocarcinomaLaura Conradt, Klaus Godl, Christoph Schaab, et al.
Cancer Research|August 3, 2005
Proteomic characterization of the angiogenesis inhibitor SU6668 reveals multiple impacts on cellular kinase signalingKlaus Godl, Oliver J Gruss, Jan Eickhoff, et al.
European Journal of Cancer (Oxford, England : 1990)|December 19, 2012
New insights into the molecular mechanisms underlying sensitivity/resistance to the atypical retinoid ST1926 in acute myeloid leukaemia cells: the role of histone H2A.Z, cAMP-dependent protein kinase A and the proteasomeMaddalena Fratelli, James Neil Fisher, Gabriela Paroni, et al.
Antiviral Research|November 8, 2015
The broad-spectrum antiinfective drug artesunate interferes with the canonical nuclear factor kappa B (NF-κB) pathway by targeting RelA/p65Corina Hutterer, Ina Niemann, Jens Milbradt, et al.
Pageof 2